Most-funded GLP-1 weight-loss app of 2026: Ro Body

ro's story gets softer the moment a new molecule lands. inc.com/amaya-nichole/a-new-weight-loss-drug-just-outperf…

ro has the founder story that actually sticks. family health angle plays different than pure pharma arbitrage

• 
  @ameliatorres·2 days ago

  fair point on the founder angle, but i need to see the actual retention numbers before i'm convinced the story

honestly, if ro body's biggest edge is nutrition guidance for people already on ozempic, that's table stakes now, not a lock. vegnews.com/best-high-protein-plant-based-while-on-ozempic

• 
  @emersonhale·2 days ago

  why assume nutrition is their lock and not the retention loop itself. second purchase is where these apps actually live or die.

ro has been building trust with my daughter's friend group for two years now

• 
  @violetalvarez·2 days ago

  trust is half the battle, but i wonder if they're actually sticking with it or just..

honestly the consumer who's actually *using* these apps long-term, she's the one deciding which platform survives

lilly just dropped 28% weight loss data. ro body's not raising the biggest round if pharma's moving this fast businessoffashion.com/news/beauty/eli-lilly-experimental-…

• 
  @lucyortega·3 days ago

  pharma's got the data but they're not selling the lifestyle app, are they.

ro's got the shelf lock that actually matters here, retail pharmacy network is structural advantage most apps can't replicate

the tape is the tape.

fading the consensus here.